MCF Advisors’s Pediatrix Medical MD Stock Holding History

MCF Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-40	Closed	-$3K	–	492
2016 Q2	$3K	Buy	+40	New	+$2.75K	﹤0.01%	436

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

MCF Advisors's MD Position: Q3 2016 in Review

MCF Advisors sold out of Pediatrix Medical (MD) in Q3 2016, closing a stake of 40 shares — an estimated $3K sold.

MCF Advisors first reported a position in MD in Q2 2016 and held it in 1 quarter. The position peaked at $3K in Q2 2016. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

MCF Advisors reported no remaining Pediatrix Medical position as of Q3 2016 after selling out during the quarter.
MCF Advisors sold 40 Pediatrix Medical shares in Q3 2016, an estimated $3K.
MCF Advisors first reported a position in Pediatrix Medical in Q2 2016 and held it in 1 quarter.
MCF Advisors's Pediatrix Medical position peaked at $3K in Q2 2016.
381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on MCF Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.